Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis ; volume:2 ; number:6 ; day:6 ; month:9 ; year:2000 ; pages:1-11 ; date:12.2000
Breast cancer research ; 2, Heft 6 (6.9.2000), 1-11, 12.2000
- Creator
-
Maaroufi, Younes
- Contributor
-
Lacroix, Marc
Lespagnard, Laurence
Journé, Fabrice
Larsimont, Denis
Leclercq, Guy
SpringerLink (Online service)
- DOI
-
10.1186/bcr92
- URN
-
urn:nbn:de:1111-2016032346456
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maaroufi, Younes
- Lacroix, Marc
- Lespagnard, Laurence
- Journé, Fabrice
- Larsimont, Denis
- Leclercq, Guy
- SpringerLink (Online service)
Other Objects (12)
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Estrogen receptor gene (ESR1) amplification occurs rarely in ovarian cancers
Urokinase receptor in cancer and vascular aging : role in intracellular proteolysis and DNA repair
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers